Needle-free injection systems involve a wide range of drug delivery methods that drive drugs through the skin by means of forces such as Shockwaves, Lorentz, pressure by gas or electrophoresis. Demand for these systems has witnessed substantial rise in recent times as they eliminate risks of needles, enhance immune response to vaccines, and cut down healthcare costs. Moreover, they enable better reproducibility and faster drug delivery as compared to conventional injection systems.
In-Depth research report on Needle-free Injection System Market : https://goo.gl/9RJd1R
High Demand for Needle-free Insulin Delivery
Key areas of application of needle-free injection systems are insulin delivery, vaccine delivery, pain management, and oncology. Vaccine delivery is anticipated to account for a large share in the global arena. Soaring demand for vaccination and biosimilars can contribute to the growth. Constant innovations in needle-free injection systems will promote the uptake of these systems for vaccine delivery. To put this in perspective, in June 2017, scientists from Georgia Institute of Technology and Emory University have developed a needle-free patch to deliver a flu vaccine. A trial conducted showed that the patches produced a reliable immune response and can be safely applied by patients themselves. The insulin delivery segment will also post promising growth in coming years, owing to increasing cases of diabetes worldwide.
Market Insights
Growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders can augment the global needle-free injection systems market, finds a report available on Radiant Insights, Inc. As per a study by the World Health Organization (WHO), the number of deaths caused by diabetes and cancer in 2015 was 1.6 million and 8.8 million respectively. Furthermore, increased cases of communicable diseases due to needlestick injuries can stoke the market growth over the forecast period (2017 to 2021).
On the flip side, high cost of development of these systems can hamper growth prospects. Availability of alternate drug delivery systems along with stringent norms pertaining to the usage of these injection systems for intravenous procedures can limit the market from realizing its utmost potential.
North America is expected to hold a prominent position in the global arena, thanks to burgeoning adoption of self-administration drug delivery systems. Some of the prominent players in the market are Antares Pharma, Pharmajet, Valeritas, Crossject, and Injex Pharma AG.
Request free sample at :
No comments:
Post a Comment